Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CBD and CBN Oral Solutions in Facial Pain and Headache of Muscular Origin
NCT05961501Phase 3Enrolling by invitation
- Sponsor
- Wroclaw Medical University
- Start
- Apr 2025
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of cannabidiol and cannabinol in Facial pain and Headache (2 arms), sponsored by Wroclaw Medical University. Primary endpoints: Pressure Pain Threshold at 3 months and Electromyography at 3 months. Started Apr 2025; status: enrolling by invitation.
02
Drugs
cannabidiolcannabinol
03
Conditions
Facial painHeadache
Beyond the preview
Go deeper on NCT05961501.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05961501.